Five thousand and eighty-eight dollars. That was the price of gold on January 26, 2026, when the metal breached $5,000 per ounce for the first time in history. Three years of relentless central bank buying had pushed the gold price to this milestone. Read more »
South Korea’s insurance industry has taken its first step onto the blockchain. On April 15, 2026, Kyobo Life Insurance — one of Korea’s largest insurers with total assets of KRW 122.4 trillion ($89B) and assets under management of approximately KRW 110 trillion ($80B) — announced a strategic partnership with Ripple to pilot the country’s first tokenized bond settlement on blockchain infrastructure. Read more »
$11.57 billion. That is the price tag Amazon just placed on its satellite war with SpaceX. On April 14, Amazon announced a definitive agreement to acquire Globalstar, the satellite communications operator that powers Apple’s iPhone Emergency SOS feature, in what amounts to the largest satellite industry acquisition in history. Read more »
One hundred percent. That was the success rate when Physical Intelligence’s latest robot brain attempted tasks it had never been trained on — zero relevant data, zero prior demonstrations on the target hardware. Read more »
Five percent. That was the China GDP print for Q1 2026, comfortably above the 4.8% that Wall Street had penciled in. On the surface, it looks like the world’s second-largest economy is firing on all cylinders. Read more »
$118 billion. That is the total value locked in Ethereum’s DeFi ecosystem right now. On April 13, the SEC issued its first-ever DeFi Safe Harbor for this massive market — and the implications ripple far beyond American borders. Read more »
$218 billion. That is the potential damage claim advertisers are preparing to file against Google. Two federal courts have already ruled against the company — one for its search monopoly in August 2024, another for its ad tech monopoly in April 2025 — and the Google antitrust reckoning is accelerating. Read more »
Drug discovery just entered a new era. On April 14, 2026, Danish pharmaceutical giant Novo Nordisk — the maker of Ozempic and Wegovy — announced a sweeping partnership with OpenAI to embed artificial intelligence agents across its entire operational chain. From genomic data analysis to supply chain optimization, every stage of how a drug is found, made, and delivered is now on the table. Read more »
$16.5 billion. That is what JPMorgan Chase earned in net income during the first three months of 2026. It is a record quarter, with all-time trading revenue, a sixth consecutive double-digit earnings growth print for the S&P 500, and the kind of Wall Street earnings that look bulletproof on paper. Read more »
“What’s the difference between an AI agent and a chatbot?” It is now the most common question in product meetings across the enterprise stack. Add LLM to the mix and the confusion doubles. Read more »